Cara Therapeutics (CARA) R&D US GAAP (year values)

2020 2021 2022 2023 2023   LTM ? CAGR 5 years ?
R&D, bln rub 107.9 82.7 91.9 108.5 108.5   61.0  
Changes by years, y/y, % -5% -23% +11% +18% 0%     +7.5%

Cara Therapeutics. R&D, bln rub

Cara Therapeutics. R&D, changes, %

Cara Therapeutics. R&D, sum by quarters, bln rub

Cara Therapeutics (CARA) R&D US GAAP (quarter values)

2023Q4 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
R&D, bln rub 28.4 28.4 22.0 9.31 1.36   61.0
Changes by years, y/y, % +9% +9% -10% -69% -95%    
Changes by quarters, q/q, % +12% 0% -23% -58% -85%    

Cara Therapeutics. R&D, bln rub

Cara Therapeutics. R&D, changes, y/y, %

Cara Therapeutics. R&D, changes, q/q, %